JP6639034B2 - 矯味剤含有顆粒を内在する、服用性が改善された口腔内崩壊錠 - Google Patents

矯味剤含有顆粒を内在する、服用性が改善された口腔内崩壊錠 Download PDF

Info

Publication number
JP6639034B2
JP6639034B2 JP2019105522A JP2019105522A JP6639034B2 JP 6639034 B2 JP6639034 B2 JP 6639034B2 JP 2019105522 A JP2019105522 A JP 2019105522A JP 2019105522 A JP2019105522 A JP 2019105522A JP 6639034 B2 JP6639034 B2 JP 6639034B2
Authority
JP
Japan
Prior art keywords
tablet
orally disintegrating
granules
drug
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2019105522A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019218339A (ja
Inventor
浩人 寺田
浩人 寺田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ohara Pharmaceutical Co Ltd
Original Assignee
Ohara Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=69095578&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP6639034(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ohara Pharmaceutical Co Ltd filed Critical Ohara Pharmaceutical Co Ltd
Publication of JP2019218339A publication Critical patent/JP2019218339A/ja
Application granted granted Critical
Publication of JP6639034B2 publication Critical patent/JP6639034B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2019105522A 2018-06-13 2019-06-05 矯味剤含有顆粒を内在する、服用性が改善された口腔内崩壊錠 Active JP6639034B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018112532 2018-06-13
JP2018112532 2018-06-13

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019230335A Division JP6847190B2 (ja) 2018-06-13 2019-12-20 矯味剤含有顆粒を内在する、服用性が改善された口腔内崩壊錠

Publications (2)

Publication Number Publication Date
JP2019218339A JP2019218339A (ja) 2019-12-26
JP6639034B2 true JP6639034B2 (ja) 2020-02-05

Family

ID=69095578

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019105522A Active JP6639034B2 (ja) 2018-06-13 2019-06-05 矯味剤含有顆粒を内在する、服用性が改善された口腔内崩壊錠
JP2019230335A Active JP6847190B2 (ja) 2018-06-13 2019-12-20 矯味剤含有顆粒を内在する、服用性が改善された口腔内崩壊錠

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019230335A Active JP6847190B2 (ja) 2018-06-13 2019-12-20 矯味剤含有顆粒を内在する、服用性が改善された口腔内崩壊錠

Country Status (1)

Country Link
JP (2) JP6639034B2 (cg-RX-API-DMAC7.html)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100034894A1 (en) * 2008-08-08 2010-02-11 Szymczak Christopher E Use of Sucralose as a Granulating Agent
JP2010202579A (ja) * 2009-03-03 2010-09-16 Sawai Pharmaceutical Co Ltd アカルボースを含有する口腔内崩壊剤
JP5420321B2 (ja) * 2009-06-22 2014-02-19 沢井製薬株式会社 ポラプレジンク含有口腔内崩壊錠
WO2010150221A1 (en) * 2009-06-25 2010-12-29 Wockhardt Research Centre Taste masked pharmaceutical compositions of pregabalin
JP5807642B2 (ja) * 2010-09-30 2015-11-10 アステラス製薬株式会社 アトルバスタチン含有医薬錠剤
JP5858486B2 (ja) * 2012-05-11 2016-02-10 塩野義製薬株式会社 アスコルビン酸、スクラロースおよびアスパルテームを含有する固形製剤
CN103271888A (zh) * 2013-06-18 2013-09-04 上海奥科达生物医药科技有限公司 普瑞巴林口崩片和分散片及其制备方法
WO2017109547A1 (es) * 2015-12-23 2017-06-29 Laboratorios Bagó S.A. Premezcla y composición farmacéutica para la administración oral de memantina como suspensión permanente o de preparación previa a la administración al paciente y optativamente por sonda de alimentación enteral y procedimientos correspondientes
JP7062368B2 (ja) * 2017-03-15 2022-05-06 武田テバファーマ株式会社 不快な味がマスキングされた経口医薬組成物
JP2019142834A (ja) * 2017-07-31 2019-08-29 大原薬品工業株式会社 プレガバリン並びに好適な賦形剤を含有する固形製剤
JP2019073478A (ja) * 2017-10-17 2019-05-16 日本ケミファ株式会社 ４−アミノブタン酸類縁体含有固形製剤及びその製造方法
JP2019147782A (ja) * 2018-02-27 2019-09-05 日本ジェネリック株式会社 プレガバリン含有固形医薬組成物及びその製造法

Also Published As

Publication number Publication date
JP2020045367A (ja) 2020-03-26
JP2019218339A (ja) 2019-12-26
JP6847190B2 (ja) 2021-03-24

Similar Documents

Publication Publication Date Title
JP5537927B2 (ja) 口腔内崩壊錠
KR101600099B1 (ko) 매트릭스형 의약 고형 제제
JP6866153B2 (ja) 圧縮成型製剤
CN101862297A (zh) 一种非水溶性药物的缓释微丸、其缓释口腔崩解片及其制备方法
JP6768984B2 (ja) 酢酸亜鉛水和物錠及びその製造方法
HK1209337A1 (en) Medicament-containing hollow particle
US20080139514A1 (en) Diphosphonic acid pharmaceutical compositions
EP2612657B1 (en) Orodispersible tablet
JP6420508B2 (ja) 化学的な安定性が改善された、メマンチン塩酸塩を含有する製剤
WO2017170854A1 (ja) 有効成分の化学的安定性に優れたフィルムコーティング錠
JP7212484B2 (ja) 腸溶性被覆顆粒の耐酸性が改善された圧縮成形製剤の製造方法
JP6366794B2 (ja) 原薬の化学的安定性や服用感を向上した、口腔内崩壊錠
JP2013237651A (ja) ピタバスタチンの口腔内崩壊錠
JP7377943B2 (ja) 固形製剤の製造方法
JP6639034B2 (ja) 矯味剤含有顆粒を内在する、服用性が改善された口腔内崩壊錠
JP2019156723A (ja) 圧縮成形性に優れた賦形剤を用いる、浸透膨潤型口腔内崩壊錠
WO2019098327A1 (ja) 速溶性薬物の苦味が抑制された口腔内崩壊錠
JP7308022B2 (ja) 速溶性薬物の苦味が抑制された口腔内崩壊錠
JP2019137669A (ja) 相対的高密度顆粒を含有する圧縮成形錠剤の工業的製造方法
JP7642026B2 (ja) 腸溶性製剤
JP7761403B2 (ja) 水不溶性ポリマーコーティング顆粒、それを含む製剤、口腔内崩壊錠及びそれらの製造方法
JP7786701B2 (ja) 腸溶性の粒状物及びそれを含有する固形製剤
JP2018172363A (ja) 腸溶性組成物中に含まれる薬物塩の溶出性を改善する方法
WO2018130943A1 (en) Oral pharmaceutical composition of lurasidone and preparation thereof
JP2024141310A (ja) 顆粒の製造方法及びフィルムコーティング錠の製造方法、並びに、顆粒及びフィルムコーティング錠

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190807

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20190807

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20190821

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190919

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20191118

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20191220

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20191220

R150 Certificate of patent or registration of utility model

Ref document number: 6639034

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R157 Certificate of patent or utility model (correction)

Free format text: JAPANESE INTERMEDIATE CODE: R157

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250